ArticleClinical trials (London, England)2010

Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials.

Anneke T Schroen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.